Amoxycillin & Potassium Clavulanate Tablets IP – Moxival CV 375 Tablets

Moxival CV 375 Tablets
Composition:- Amoxycillin 250 mg + Potassium Clavulanate 125 mg.

Amoxycillin & Potassium Clavulanate Tablets IP – The dual composition of Amoxycillin & Potassium Clavulanate Tablets IP effectively treats infections caused by beta-lactamase-producing bacteria, offering superior clinical outcomes in managing bacterial infections.

Amoxicillin – A broad-spectrum penicillin antibiotic that inhibits bacterial cell wall synthesis, leading to bacterial cell death.
Potassium Clavulanate – A beta-lactamase inhibitor that protects amoxicillin from degradation by neutralizing the beta-lactamase enzymes produced by resistant bacteria.

Key Points of Amoxycillin & Potassium Clavulanate Tablets IP – Moxival CV 375 Tablets

• Enhanced Spectrum of Action – The combination targets beta-lactamase-producing bacteria, covering a wide range of Gram-positive and Gram-negative pathogens.
• Effective Against Resistant Strains – Potassium clavulanate neutralizes beta-lactamase enzymes, restoring amoxicillin’s efficacy against resistant bacterial strains.
• Broad Indication Range – Ideal for respiratory, urinary, skin, and soft tissue infections, delivering consistent and reliable results.

Can be Prescribed by:

• General Physicians
• Pulmonologists (Chest Specialists)
• Urologists
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.